Genmab Files Annual Report with the U.S. Securities and Exchange Commission
12/2 19:14
Media Release COPENHAGEN, Denmark; February 12, 2025 Genmab filed Form 20-F for the financial year 2024 with the U.S. SEC Genmab A/S (Nasdaq: GMAB) announced...
Læs mere »...